Aquestive Therapeutics, Inc. (AQST) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$8.22M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$4.20M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$11.48M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$11.37M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2017-06-30 to 2018-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$8.22M | (m) | $13.82M | (m) | $212.00K* | -$9.44M* | $4.02M | $3.96M | $14.06M | $0.00 |
|---|
| 2026-03-31 | Reported | (m) | -$4.20M | (m) | $14.45M | (m) | $52.00K | -$14.81M | $3.47M | $4.20M | $10.98M | $0.00 |
|---|
| 2025-09-30 | Reported | (m) | -$11.48M | (m) | $12.81M | (m) | $235.00K* | -$12.65M* | $4.51M | $4.53M | $15.25M | $0.00 |
|---|
| 2025-06-30 | Reported | (m) | -$11.37M | (m) | $10.00M | (m) | $107.00K* | -$7.91M* | $4.56M | $4.11M | $12.71M | $0.00 |
|---|
| 2025-03-31 | Reported | (m) | -$19.36M | (m) | $8.72M | (m) | $135.00K | -$23.40M | $3.65M | $5.36M | $19.07M | $0.00 |
|---|
| 2024-09-30 | Reported | (m) | -$8.29M | (m) | $13.54M | (m) | $80.00K* | -$11.88M* | $4.44M | $5.27M | $12.13M | $0.00 |
|---|
| 2024-06-30 | Reported | (m) | $55.00K | (m) | $20.10M | (m) | $35.00K* | -$7.01M* | $4.53M | $4.16M | $11.36M | $0.00 |
|---|
| 2024-03-31 | Reported | (m) | -$8.96M | (m) | $12.05M | (m) | $29.00K | -$10.38M | $4.39M | $5.93M | $10.69M | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$2.38M | (m) | $13.00M | (m) | $151.00K* | -$2.35M* | $4.80M | $3.20M | $7.38M | -$140.00K |
|---|
| 2023-06-30 | Reported | (m) | -$4.21M | (m) | $13.24M | (m) | $826.00K* | -$7.91M* | $6.62M | $3.47M | $7.36M | $284.00K |
|---|
| 2023-03-31 | Reported | (m) | -$4.61M | (m) | $11.13M | (m) | $2.00K | $8.82M | $4.74M | $3.55M | $7.46M | $0.00 |
|---|
| 2022-09-30 | Reported | (m) | -$8.85M | (m) | $11.46M | (m) | $217.00K* | $2.81M* | $4.63M | $3.23M | $12.46M | $0.00 |
|---|
| 2022-06-30 | Reported | (m) | -$12.76M | (m) | $13.27M | (m) | $677.00K* | -$6.56M* | $5.24M | $5.20M | $15.59M | $0.00 |
|---|
| 2022-03-31 | Reported | (m) | -$9.74M | (m) | $12.27M | (m) | $104.00K | -$14.48M | $4.21M | $4.77M | $13.02M | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$7.97M | (m) | $13.29M | (m) | $83.00K* | -$9.06M* | $4.40M | $4.73M | $12.13M | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$6.52M | (m) | $15.35M | (m) | $194.00K* | -$1.76M* | $4.47M | $4.26M | $13.13M | $0.00 |
|---|
| 2021-03-31 | Reported | (m) | -$8.53M | (m) | $11.12M | (m) | $103.00K | -$14.10M | $2.76M | $3.66M | $13.23M | $0.00 |
|---|
| 2020-09-30 | Reported | (m) | -$13.78M | (m) | $8.26M | (m) | $38.00K* | -$8.31M* | $2.98M | $7.26M | $11.80M | $0.00 |
|---|
| 2020-06-30 | Reported | (m) | $395.00K | (m) | $21.68M | (m) | $112.00K* | -$10.00M* | $3.54M | $3.85M | $13.89M | $0.00 |
|---|
| 2020-03-31 | Reported | (m) | -$13.86M | (m) | $8.77M | (m) | $131.00K | -$13.64M | $3.66M | $4.35M | $14.61M | $0.00 |
|---|
| 2019-09-30 | Reported | (m) | -$11.00M | (m) | $12.42M | (m) | $91.00K* | -$14.79M* | $4.64M | $5.06M | $13.71M | $0.00 |
|---|
| 2019-06-30 | Reported | (m) | -$18.69M | (m) | $11.13M | (m) | $110.00K* | -$17.17M* | $5.42M | $8.15M | $16.25M | $0.00 |
|---|
| 2019-03-31 | Reported | (m) | -$13.07M | (m) | $12.64M | (m) | $376.00K | -$17.68M | $3.51M | $4.30M | $17.91M | $0.00 |
|---|
| 2018-12-31 | Reported | -$11.6M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | -$8.47M | (m) | (m) | (m) | (m) | $448.00K* | -$11.47M* | (m) | $4.53M | $12.35M | $0.00 |
|---|
| 2018-06-30 | Reported | -$31.94M | (m) | (m) | (m) | (m) | $627.00K* | $511.00K* | (m) | $7.99M | $33.67M | $0.00 |
|---|
| 2018-03-31 | Reported | (m) | $5.30M | (m) | $23.41M | (m) | $259.00K | $785.00K | (m) | $4.90M | $7.57M | $0.00 |
|---|
| 2017-12-31 | Reported | -$6.3M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-09-30 | Reported | $11.37M | (m) | (m) | (m) | (m) | $433.00K* | $15.63M* | (m) | $5.68M | $6.16M | $0.00 |
|---|
| 2017-06-30 | Reported | -$3.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.84M | $5.22M | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$71.05M | (m) | $44.55M | (m) | $562.00K | -$52.43M | $18.55M | $17.19M | $79.85M | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$30.77M | (m) | $57.56M | (m) | $159.00K | -$35.76M | $17.87M | $20.28M | $50.18M | -$14.00K |
|---|
| 2023-12-31 | Reported | (m) | -$15.10M | (m) | $50.58M | (m) | $995.00K | -$6.38M | $20.83M | $13.10M | $31.75M | $245.00K |
|---|
| 2022-12-31 | Reported | (m) | -$42.07M | (m) | $47.68M | (m) | $1.02M | -$9.82M | $19.39M | $17.48M | $52.88M | $0.00 |
|---|
| 2021-12-31 | Reported | (m) | -$34.68M | (m) | $50.83M | (m) | $913.00K | -$32.98M | (m) | $17.05M | $53.48M | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$42.89M | (m) | $45.85M | (m) | $517.00K | -$45.46M | $12.96M | $19.89M | $55.89M | $0.00 |
|---|
| 2019-12-31 | Reported | (m) | -$52.67M | (m) | $52.61M | (m) | $663.00K | -$60.21M | $20.36M | $20.57M | $64.34M | $0.00 |
|---|
| 2018-12-31 | Reported | -$45.75M | (m) | (m) | (m) | (m) | $1.82M | -$12.99M | (m) | $23.11M | $72.27M | $0.00 |
|---|
| 2017-12-31 | Reported | $3.64M | (m) | (m) | (m) | (m) | $2.07M | $5.82M | (m) | $22.13M | $25.08M | $0.00 |
|---|